Form 4: CME Director Harold Ford Jr. Sells 1,000 Shares

CME Group Inc. Director Harold Ford Jr. sold 1,000 shares of Class A common stock on November 3, 2025, for a weighted average price of $263.53.

Summary

• Harold Eugene Ford Jr., a Director of CME Group Inc. (CME), reported a sale of common stock.
• On November 3, 2025, Mr. Ford sold 1,000 shares of CME Group Class A common stock.
• The shares were sold at a weighted average price of $263.53 per share, with the price range being $263.21 to $263.68.
• Following this transaction, Mr. Ford beneficially owns 1,091 shares of CME Group Class A common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sale of shares by a director, while executed under a pre-arranged 10b5-1 plan, can sometimes be perceived as a neutral to slightly negative signal by the market. However, the relatively small number of shares sold compared to the company's market capitalization and the pre-planned nature mitigate significant negative sentiment.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged sale rather than a reaction to immediate news, which can mitigate negative interpretations of insider selling.

Negatives

• A director selling shares can sometimes be interpreted by the market as a lack of confidence in the company's near-term prospects, even if pre-planned.

Future Outlook

NA

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. Insider sales are typically company-specific events.

Stakeholder Impact

• Shareholders: May interpret the director's sale as a neutral to slightly negative signal, potentially influencing short-term sentiment.

Key Dates

Recommendation

While a director's sale of shares can sometimes be a negative signal, this transaction was executed under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not based on new, adverse information. The number of shares sold (1,000) is also relatively small. Investors should monitor future insider activity and broader company performance rather than reacting solely to this single transaction. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while observing further developments.

Keywords

CME Group Inc., CME, Harold Ford Jr., Director, Insider Trading, Stock Sale, Form 4, Equity Transaction, Beneficial Ownership, 10b5-1 Plan